• Novartis
    Cataract/Anterior Segment, Comprehensive Ophthalmology, Refractive Mgmt/Intervention, Retina/Vitreous

    The agreement with Google[x], a team within Google devoted to finding new solutions to global problems, will allow Alcon to develop Google’s “smart lens” technology to manage ocular conditions. The agreement remains subject to anti-trust approvals.

    Novartis’ interest in “smart lens” technology – which involves non-invasive sensors, microchips and other miniaturized electronics embedded within contact lenses – is currently focused on two areas:

    • The “smart lens” has the potential to provide accommodative vision correction to people with presbyopia via an accommodative contact lens or IOL;
    • Helping diabetic patients manage their disease by providing a continuous, minimally invasive measurement of glucose levels via a “smart contact lens” that measures tear fluid and connects wirelessly with a mobile device.

     “We are looking forward to working with Google to bring together their advanced technology and our extensive knowledge of biology to meet unmet medical needs,” said Novartis CEO Joseph Jimenez. “This is a key step for us to go beyond the confines of traditional disease management, starting with the eye.”

    “Our dream is to use the latest technology in the miniaturization of electronics to help improve the quality of life for millions of people,” said Google co-founder Sergey Brin. “We are very excited to work with Novartis to make this dream come true."